These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Effective switch from premixed to basal-prandial insulin to achieve glycemic goals in type 2 diabetes.
    Author: Lavernia F.
    Journal: Postgrad Med; 2010 May; 122(3):28-32. PubMed ID: 20463411.
    Abstract:
    OBJECTIVE: This article describes a patient with type 2 diabetes mellitus achieving glycemic control after transitioning from premixed to basal-prandial insulin. METHODS: A case report illustrates the challenges of achieving glycemic control in type 2 diabetes, and results of a literature search regarding premixed and basal-prandial insulins are presented. RESULTS: A 52-year-old obese man with type 2 diabetes for 10 years initiated therapy with 2 oral antidiabetic drugs (OADs). When OAD therapy no longer maintained glycemic targets, and the addition of exenatide proved intolerable, he started premixed insulin aspart 70/30. However, lapses in exercise and irregular meal patterns led to a loss of glycemic control and nocturnal hypoglycemia. Switching to a basal-prandial regimen, starting with basal insulin glargine and then adding prandial insulin glulisine, subsequently resulted in a glycated hemoglobin level of 6.7%. CONCLUSION: The patient benefited from the addition of 1 or more prandial insulin injections to a once-daily basal insulin analog.
    [Abstract] [Full Text] [Related] [New Search]